000 | 00998 a2200289 4500 | ||
---|---|---|---|
005 | 20250514002644.0 | ||
264 | 0 | _c20011101 | |
008 | 200111s 0 0 eng d | ||
022 | _a0114-5916 | ||
024 | 7 |
_a10.2165/00002018-200124050-00002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJansman, F G | |
245 | 0 | 0 |
_aManagement of chemotherapy-induced adverse effects in the treatment of colorectal cancer. _h[electronic resource] |
260 |
_bDrug safety _c2001 |
||
300 |
_a353-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aQuality of Life |
700 | 1 | _aSleijfer, D T | |
700 | 1 | _ade Graaf, J C | |
700 | 1 | _aCoenen, J L | |
700 | 1 | _aBrouwers, J R | |
773 | 0 |
_tDrug safety _gvol. 24 _gno. 5 _gp. 353-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-200124050-00002 _zAvailable from publisher's website |
999 |
_c11349290 _d11349290 |